Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia B, Congenital”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT05856266
What this trial is testing

An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa

Who this might be right for
Hemophilia AHemophilia B
Swedish Orphan Biovitrum 10
Testing effectiveness (Phase 2)Study completedNCT02396342
What this trial is testing

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 10
Large-scale testing (Phase 3)Study completedNCT00543439
What this trial is testing

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Who this might be right for
Hemophilia A
Pfizer 66
Large-scale testing (Phase 3)Study completedNCT01286779
What this trial is testing

BAX 326 (rFIX) Continuation Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 117
Not applicableStudy completedNCT04272554
What this trial is testing

AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)

Who this might be right for
Hemophilia BBlood Coagulation Disorders, InheritedBlood Coagulation Disorder+1 more
Spur Therapeutics 37
Not applicableEnded earlyNCT02392156
What this trial is testing

Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes

Who this might be right for
Hemophilia AHemophilia B
Bioverativ Therapeutics Inc. 3
Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Not applicableUnknownNCT06158334
What this trial is testing

Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)

Who this might be right for
Hemophilia AHemophilia B
Hospices Civils de Lyon 400
Large-scale testing (Phase 3)Study completedNCT01386528
What this trial is testing

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 13
Not applicableStudy completedNCT00703911
What this trial is testing

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 102
Not applicableEnded earlyNCT04628871
What this trial is testing

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

Who this might be right for
Hemophilia BMucopolysaccharidosis IMucopolysaccharidosis II
Sangamo Therapeutics 13
Not applicableUnknownNCT02502409
What this trial is testing

Natural History Study of Factor IX Treatment and Complications

Who this might be right for
Factor IX Deficiency
Skane University Hospital 550
Testing effectiveness (Phase 2)Study completedNCT00004801
What this trial is testing

Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

Who this might be right for
Hemophilia BFactor IX Deficiency
National Center for Research Resources (NCRR) 3
Not applicableStudy completedNCT01029808
What this trial is testing

Bleeding Symptoms of Carriers of Hemophilia A and B

Who this might be right for
Hemophilia
Sahlgrenska University Hospital 126
Post-approval studies (Phase 4)Looking for participantsNCT04647227
What this trial is testing

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis Network 55
Large-scale testing (Phase 3)Looking for participantsNCT05145127
What this trial is testing

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Pfizer 245
Not applicableStudy completedNCT03623295
What this trial is testing

The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B

Who this might be right for
Hemophilia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 304
Not applicableUnknownNCT02938156
What this trial is testing

UK - EHL Outcomes Registry

Who this might be right for
Hemophilia AHemophilia B
Royal Free Hospital NHS Foundation Trust 500
Not applicableStudy completedNCT00853086
What this trial is testing

Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 139
Next Page